Here you will find insights from our team and contributions from leading biotech entrepreneurs. We plan to feature a mix of articles, thoughts and commentary around our investments, as well as news and trends in the biotech industry.
3rd May 2023
Arix Bioscience Announces Results for Year Ended 31st December 2022
20th December 2022
Arix Bioscience Presents at Mello Investment Trusts and Funds
30th June 2022
Investor Meet Company Presentation
9th March 2021
COO, Robert Lyne, discusses 2020 Annual Results
9th November 2020
Arix’s first M&A exit: VelosBio to be acquired by Merck for $2.75bn in cash
8th July 2020
VelosBio closes $137m Series B
7th May 2020
Niall Martin, CEO of Artios, interview
5th May 2020
Amplyx CEO on COVID-19 and Fungal Superinfections
11th December 2019
Elisabet de los Pinos, CEO of Aura Biosciences Interview
4th December 2019
Dave Johnson, CEO of VelosBio interview
20th June 2019
'EU Gives Lynparza Green Light as First-Line Ovarian Cancer Treatment' - Artios CEO interviewed by Labiotech